N/A
Manufactured by Eli Lilly and Company
10 FDA adverse event reports analyzed
Last updated: 2026-05-19
Mounjaro is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Eli Lilly and Company. The most commonly reported adverse reactions for Mounjaro include INABILITY TO AFFORD MEDICATION, ABDOMINAL PAIN UPPER, ANXIETY, FOURNIER^S GANGRENE, GASTRITIS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Mounjaro.
Out of 4 classified reports for Mounjaro:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 10 FDA FAERS reports that mention Mounjaro. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include INABILITY TO AFFORD MEDICATION, ABDOMINAL PAIN UPPER, ANXIETY, FOURNIER^S GANGRENE, GASTRITIS, INJECTION SITE PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Eli Lilly and Company in connection with Mounjaro. Always verify the specific product and NDC with your pharmacist.
Explore other medications manufactured by Eli Lilly and Company and compare their safety profiles:
The following drugs share commonly reported adverse reactions with Mounjaro: